State of Wyoming’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

State of Wyoming’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,862	Closed	-$203K	–	1849
2023 Q1	$203K	Buy	+1,862	New	+$206K	0.07%	329
2022 Q4	–	Sell	-3,167	Closed	-$196K	–	1825
2022 Q3	$196K	Buy	3,167 +2,744	+649%	+$192K	0.1%	205
2022 Q2	$34K	Buy	423 +384	+985%	+$36.4K	0.02%	1201
2022 Q1	$4K	Buy	39 +7	+22%	+$682	﹤0.01%	1680
2021 Q4	$3K	Sell	32 -3	-9%	-$327	﹤0.01%	1764
2021 Q3	$4K	Sell	35 -16	-31%	-$1.66K	﹤0.01%	1125
2021 Q2	$5K	Buy	51 +27	+113%	+$2.48K	﹤0.01%	1079
2021 Q1	$2K	Buy	+24	New	+$2.02K	﹤0.01%	478

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State of Wyoming's HZNP Position: Q2 2023 in Review

State of Wyoming sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 1,862 shares — an estimated $203K sold.

State of Wyoming first reported a position in HZNP in Q1 2021 and held it in 8 quarters. The position peaked at $203K in Q1 2023. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

State of Wyoming reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
State of Wyoming sold 1,862 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $203K.
State of Wyoming first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 8 quarters.
State of Wyoming's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $203K in Q1 2023.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on State of Wyoming's 13F filing for Q2 2023, filed 14 Aug 2023.